Eulerpool Data & Analytics INHIBIKASE THERAPEUTICS, INC. WILMINGTON, US-DE
Nombre
INHIBIKASE THERAPEUTICS, INC.
Dirección
INHIBIKASE THERAPEUTICS, INC.
c/o PHS CORPORATE SERVICES
INC.
1313 N MARKET ST STE 5100
19801 WILMINGTON
Sede
3350 Riverwood Parkway Southeast; Suite 1900, 30339 Atlanta
Legal Entity Identifier (LEI)
549300066CFEWOA17F12
Legal Operating Unit (LOU)
5299000J2N45DDNE4Y28
Número de registro
4832244
Forma jurídica
XTIQ
Categoría de la empresa
General
Estado
Emitido
Estado de validación
Completamente Confirmado
Última actualización
29/8/2023
Próxima renovación
29/8/2024
Eulerpool API INHIBIKASE THERAPEUTICS, INC. Ventas, Beneficio, Balance, Patentes, Empleados y más WILMINGTON, US-DE
{
"lei": "549300066CFEWOA17F12",
"legal_jurisdiction": "US-DE",
"legal_name": "INHIBIKASE THERAPEUTICS, INC.",
"entity_category": "GENERAL",
"entity_legal_form_code": "XTIQ",
"legal_first_address_line": "c/o PHS CORPORATE SERVICES, INC., 1313 N MARKET ST STE 5100",
"legal_additional_address_line": "",
"legal_city": "WILMINGTON",
"legal_postal_code": "19801",
"headquarters_first_address_line": "3350 Riverwood Parkway Southeast; Suite 1900",
"headquarters_additional_address_line": "",
"headquarters_city": "Atlanta",
"headquarters_postal_code": "30339",
"registration_authority_entity_id": "4832244",
"next_renewal_date": "2024-08-29T13:00:07.000Z",
"last_update_date": "2023-08-29T13:00:07.000Z",
"managing_lou": "5299000J2N45DDNE4Y28",
"registration_status": "ISSUED",
"validation_sources": "FULLY_CORROBORATED",
"reporting_exception": "",
"slug": "INHIBIKASE THERAPEUTICS, INC.,WILMINGTON,4832244"
}Otras empresas en la misma jurisdicción